Therefore, analyses of Ang-2 expression on tumor tissue using IHC and including larger cohorts might be of great interest to validate the predictive role of Ang-2 in ovarian cancer patients treated with bevacizumab therapy. The gene discussed is ANGPT2; the disease is ovarian carcinoma.